Compound ID | 2306
LPC-233
Class: Lipopolysaccharide synthesis inhibitor
| Spectrum of activity: | Gram-negative |
| Details of activity: | Active against Pseudomonas aeruginosa LpxC |
| Description: | No detectable adverse cardiovascular toxicity in dogs at 100 milligrams per kilogram; in preclinical evaluation |
| Year first mentioned: | 2023 |
| Development status: | Preclinical evaluation |
| External links: | |
| Main Source: | https://www.science.org/doi/10.1126/scitranslmed.adf5668 |
AntibioticDB is supported by GARDP.
If you have feedback, experience problems, or are interested in a collaboration, please contact us.
The content of this site is intended for educational and scientific research purposes only and not as a source of medical advice or consultation.